Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Aemetis (AMTX) EBT (2016 - 2025)

Aemetis has reported EBT over the past 14 years, most recently at -$14.3 million for Q4 2025.

  • Quarterly results put EBT at -$14.3 million for Q4 2025, up 49.99% from a year ago — trailing twelve months through Dec 2025 was -$93.3 million (up 5.19% YoY), and the annual figure for FY2025 was -$93.3 million, up 5.19%.
  • EBT for Q4 2025 was -$14.3 million at Aemetis, up from -$23.7 million in the prior quarter.
  • Over the last five years, EBT for AMTX hit a ceiling of $44.7 million in Q4 2021 and a floor of -$66.8 million in Q3 2022.
  • Median EBT over the past 5 years was -$23.5 million (2024), compared with a mean of -$20.4 million.
  • Biggest five-year swings in EBT: skyrocketed 392.3% in 2021 and later plummeted 11653.88% in 2023.
  • Aemetis' EBT stood at $44.7 million in 2021, then crashed by 147.8% to -$21.4 million in 2022, then crashed by 48.45% to -$31.7 million in 2023, then rose by 9.95% to -$28.6 million in 2024, then skyrocketed by 49.99% to -$14.3 million in 2025.
  • The last three reported values for EBT were -$14.3 million (Q4 2025), -$23.7 million (Q3 2025), and -$23.9 million (Q2 2025) per Business Quant data.